A detailed history of Truvestments Capital LLC transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 41 shares of TSVT stock, worth $122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Holding current value
$122
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.85 - $5.05 $157 - $207
41 New
41 $0
Q4 2022

Feb 13, 2023

SELL
$8.57 - $17.0 $17 - $34
-2 Reduced 4.65%
41 $0
Q2 2022

Aug 09, 2022

BUY
$10.55 - $18.81 $453 - $808
43 New
43 $1,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $113M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.